Autopsy report · NCT01441531
Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension
Cause of deathSlow enrollment
“Unable to recruit patient due to surgical case type. Not worth continuing study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Tourniquet-induced Pain; Tourniquet-induced Hypertension
- Interventions
- gabapentin 600 mg po; Placebo pill given one hour before surgery
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Bone Healing in Healthy and Post-menopausal Osteoporotic Women
“Unable to recruit suitable patients” - Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
“not able to recruit patients” - Nitropaste in Breast Reduction
“Unable to recruit patients” - Slings and Their Effect on Skin Pressure
“unable to recruit patients for study” - Radical Lung Radiotherapy Plus Nelfinavir
“failed to recruit, no suitable patients”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.